Evidence map›Paper›PMID 27933206›Full record

ReviewRMD open2016

Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools.

Piet van Riel, Rieke Alten, Bernard Combe, Diana Abdulganieva, Paola Bousquet, Molly Courtenay, Cinzia Curiale, Antonio Gómez-Centeno, Glenn Haugeberg, Burkhard Leeb and 4 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in RMD open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04536844 (Telehealth Follow-up in Patients With Rheumatoid Arthritis. A Noninferiority Randomized Control Trial), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04536844 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Telehealth Follow-up in Patients With Rheumatoid Arthritis. A Noninferiority Randomized Control Trial

TypeinterventionalSponsorVestre Viken Hospital TrustRan2020 to 2021Enrolled220ConditionsRheumatoid Arthritis, Treatment ComplianceArmsMobile application MyDignio (follow disease activity by assigning questionnaires to participants), Conventional prescheduled follow-up
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 10 countries.

Piet van RielRadboud University Medical Centre, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, The Netherlands; Department of Rheumatology, Bernhoven, Uden, The Netherlands.
Rieke AltenDepartment Internal Medicine, Rheumatology , Schlosspark Klinik University Medicine Berlin , Berlin , Germany.ORCID 0000-0002-3395-4412
Bernard CombeDépartement de Rhumatologie , Hôpital Lapeyronie, Montpellier Université , Montpellier , France.
Diana AbdulganievaDepartment of Internal Medicine , Kazan State Medical University , Kazan , Russia.
Paola BousquetPfizer Regional Medical Team , Rome , Italy.
Molly CourtenaySchool of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University , Wales , UK.
Cinzia CurialePfizer , Rome , Italy.
Antonio Gómez-CentenoDepartment of Rheumatology , Parc Taulí Hospital Universitari , Sabadell , Spain.
Glenn HaugebergDepartment of Rheumatology , Martina Hansens Hospital , Bærum , Norway.
Burkhard LeebLandesklinikum Stockerau, Center for Rheumatology Lower Austria,Stockerau, Austria; Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria; Department for Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
Kari PuolakkaDepartment of Medicine , South Karelia Central Hospital , Lappeenranta , Finland.
Angelo RavelliUniversity of Genoa and Istituto Giannina Gaslini , Genoa , Italy.
Bernhard RintelenLandesklinikum Stockerau, Center for Rheumatology Lower Austria,Stockerau, Austria; Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria.
Piercarlo Sarzi-PuttiniDepartment of Internal Medicine , University of Milan , Milano , Italy.
Pfizer (Italy) · ITCardiff University · GBCorporació Sanitària Parc Taulí · ESIstituto Giannina Gaslini · ITKazan State Medical University · RULandesklinikum Korneuburg · ATMartina Hansens Hospital · NOMedical University of Graz · ATRadboud University Nijmegen · NLSchlosspark-Klinik · DESouth Karelia Central Hospital · FIUniversité de Montpellier · FRUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating to target by monitoring disease activity and adjusting therapy to attain remission or low disease activity has been shown to lead to improved outcomes in chronic rheumatic diseases such as rheumatoid arthritis and spondyloarthritis. Patient-reported outcomes, used in conjunction with clinical measures, add an important perspective of disease activity as perceived by the patient. Several validated PROs are available for inflammatory arthritis, and advances in electronic patient monitoring tools are helping patients with chronic diseases to self-monitor and assess their symptoms and health. Frequent patient monitoring could potentially lead to the early identification of disease flares or adverse events, early intervention for patients who may require treatment adaptation, and possibly reduced appointment frequency for those with stable disease. A literature search was conducted to evaluate the potential role of patient self-monitoring and innovative monitoring of tools in optimising disease control in inflammatory arthritis. Experience from the treatment of congestive heart failure, diabetes and hypertension shows improved outcomes with remote electronic self-monitoring by patients. In inflammatory arthritis, electronic self-monitoring has been shown to be feasible in patients despite manual disability and to be acceptable to older patients. Patients' self-assessment of disease activity using such methods correlates well with disease activity assessed by rheumatologists. This review also describes several remote monitoring tools that are being developed and used in inflammatory arthritis, offering the potential to improve disease management and reduce pressure on specialists.

Indexed as

Disease ActivityPatient perspectiveRheumatoid Arthritis

Identifiers

PMID27933206
PMCPMC5133416
OpenAlexW2553187557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.